StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories abbott India — Operating Profit / EBITDA (INR Crores)

Abbott India Limited Filings (NSE: ABBOTINDIA / Screener.in)

QuarterlyAnnual
Latest, Q2 2026
522
Period ended Jun 30, 2026
Change on a year earlier
+17.0%
446 in Q2 2025
History
13 quarters
Since Q2 2023
Sources
1
Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAbbott India — Operating Profit / EBITDA (INR Crores)Year on yearSource
Q2 2026Jun 30, 2026522+17.0%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2026Mar 31, 2026481+12.1%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2025Dec 31, 2025463+6.2%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2025Sep 30, 2025502+14.4%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2025Jun 30, 2025446+14.1%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2025Mar 31, 2025429+30.0%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2024Dec 31, 2024436+12.4%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2024Sep 30, 2024439+15.2%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2024Jun 30, 2024391+10.1%Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2024Mar 31, 2024330–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2023Dec 31, 2023388–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2023Sep 30, 2023381–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2023Jun 30, 2023355–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗

Cite this data

StockData. (2026). Abbott Laboratories Abbott India — Operating Profit / EBITDA (INR Crores), quarterly Q2 2023–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ind-op-profit

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.